Sylvester, Others Collaborate to Eliminate Cervical Cancer
Nanoparticle Therapy Shrinks Tumors, Extends Survival in Preclinical Models
A new study has discovered that magnetoelectric nanoparticles – tiny, wirelessly controlled particles activated by magnetic fields – can both locate and destroy pancreatic tumors in preclinical models. This technology, developed by Sylvester scientists and University of Miami engineers in collaboration with Moffitt Cancer Center and Cellular Nanomed, offers a potentially new, minimally invasive way to treat one of the deadliest cancers. The study appeared this month in Advanced Science .
New Institute Launch Marks Giant Leap for Cancer Survivors (Video Available)
Recognizing the vital role that survivorship efforts play in the well-being of cancer patients, Sylvester has launched its Survivorship and Supportive Care Institute (SCCI), one of only a handful of such institutes nationwide. The SCCI not only provides evidence-based care for survivors, but also offers opportunities for innovative research covering cancer care delivery, digital health and community engagement. Frank Penedo, Ph.D. , is the institute’s director and Carmen Calfa, M.D. , is medical director.
Sylvester, UM to Train Next-Gen Experts in Exercise Oncology
Exercise as medicine is a concept gaining traction in cancer care because research and real-world observation have shown it can reduce fatigue, improve mood and lower recurrence risk. Until now, however, there were few opportunities to become certified in this budding specialty. That will change next year, when Sylvester and the University of Miami pilot an 18-month academic and internship program in exercise oncology. It’s the brainchild of Tracy Crane, Ph.D., RDN , director of lifestyle medicine, prevention and digital health at Sylvester.
Sylvester Scientists Highlight Research at Hematology Annual Meeting
Sylvester physicians and other researchers will contribute to more than 150 oral and poster presentations at ASH 2025 , the annual meeting and conference of the American Society of Hematology, Dec. 6-9, in Orlando, Florida. For abstracts, more information or to arrange interviews under embargo, email Sandy Van .
# # #